These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 12365377

  • 1. Breast cancer takes up 99mTc bombesin. A preliminary report.
    Scopinaro F, Varvarigou A, Ussof W, De Vincentis G, Archimandritis S, Evangelatos G, Corleto V, Pulcini A, Capoccetti F, Remediani S, Massa R.
    Tumori; 2002; 88(3):S25-8. PubMed ID: 12365377
    [Abstract] [Full Text] [Related]

  • 2. Phase I trial of technetium [Leu13] bombesin as cancer seeking agent: possible scintigraphic guide for surgery?
    De Vincentis G, Scopinaro F, Varvarigou A, Ussof W, Schillaci O, Archimandritis S, Corleto V, Longo F, Delle Fave G.
    Tumori; 2002; 88(3):S28-30. PubMed ID: 12365378
    [Abstract] [Full Text] [Related]

  • 3. Technetium labeled bombesin-like peptide: preliminary report on breast cancer uptake in patients.
    Scopinaro F, Varvarigou AD, Ussof W, De Vincentis G, Sourlingas TG, Evangelatos GP, Datsteris J, Archimandritis SC.
    Cancer Biother Radiopharm; 2002 Jun; 17(3):327-35. PubMed ID: 12136525
    [Abstract] [Full Text] [Related]

  • 4. Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women.
    Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Pichardo-Romero PA.
    Nucl Med Commun; 2008 Aug; 29(8):741-7. PubMed ID: 18753829
    [Abstract] [Full Text] [Related]

  • 5. A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation.
    Lin KS, Luu A, Baidoo KE, Hashemzadeh-Gargari H, Chen MK, Brenneman K, Pili R, Pomper M, Carducci MA, Wagner HN.
    Bioconjug Chem; 2005 Aug; 16(1):43-50. PubMed ID: 15656574
    [Abstract] [Full Text] [Related]

  • 6. 99MTC [13LEU] bombesin and a new gamma camera, the imaging probe, are able to guide mammotome breast biopsy.
    Soluri A, Scopinaro F, De Vincentis G, Varvarigou A, Scafé R, Massa R, Schillaci O, Spanu A, David V.
    Anticancer Res; 2003 Aug; 23(3A):2139-42. PubMed ID: 12894588
    [Abstract] [Full Text] [Related]

  • 7. Fast cancer uptake of 99mTc-labelled bombesin (99mTc BN1).
    Scopinaro F, Di Santo GP, Tofani A, Massari R, Trotta C, Ragone M, Archimandritis S, Varvarigou AD.
    In Vivo; 2005 Aug; 19(6):1071-6. PubMed ID: 16277024
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, radiolabelling and biological characteristics of a bombesin peptide analog as a tumor imaging agent.
    Okarvi SM, al-Jammaz I.
    Anticancer Res; 2003 Aug; 23(3B):2745-50. PubMed ID: 12894569
    [Abstract] [Full Text] [Related]

  • 9. [Breast carcinoma and the axillary lymph node status: the use of 99mTc-sestamibi scintimammography for the diagnosis and preoperative staging. Preliminary results].
    Cistaro A, Bonazzi G, Bellò M, Bessone M, Tetti M, Villata E, Coluccia C, Bisi G, Massaioli N.
    Minerva Chir; 1997 Oct; 52(10):1177-82. PubMed ID: 9471568
    [Abstract] [Full Text] [Related]

  • 10. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer.
    Taillefer R, Robidoux A, Turpin S, Lambert R, Cantin J, Léveillé J.
    J Nucl Med; 1998 Mar; 39(3):459-64. PubMed ID: 9529292
    [Abstract] [Full Text] [Related]

  • 11. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
    Gommans GM, van der Zant FM, van Dongen A, Boer RO, Teule GJ, de Waard JW.
    Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
    [Abstract] [Full Text] [Related]

  • 12. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
    Taillefer R, Robidoux A, Lambert R, Turpin S, Laperrière J.
    J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
    [Abstract] [Full Text] [Related]

  • 13. In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography.
    Mezi S, Primi F, Capoccetti F, Scopinaro F, Modesti M, Schillaci O.
    Int J Oncol; 2003 Jun; 22(6):1233-40. PubMed ID: 12738988
    [Abstract] [Full Text] [Related]

  • 14. Comparative evaluation of 99mTc-MIBI and 99mTc-HMDP scintimammography for the diagnosis of breast cancer and its axillary metastases.
    Nishiyama Y, Yamamoto Y, Ono Y, Irie A, Yamauchi A, Satoh K, Ohkawa M.
    Eur J Nucl Med; 2001 Apr; 28(4):522-8. PubMed ID: 11357504
    [Abstract] [Full Text] [Related]

  • 15. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
    Papantoniou V, Christodoulidou J, Papadaki E, Valotassiou V, Stipsanelli A, Louvrou A, Lazaris D, Sotiropoulou M, Pampouras G, Keramopoulos A, Michalas S, Zerva C.
    Eur J Nucl Med; 2001 Jul; 28(7):923-8. PubMed ID: 11504092
    [Abstract] [Full Text] [Related]

  • 16. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Ramírez Fde M, Luna-Gutiérrez MA, Pedraza-López M, García-Becerra R, Ordaz-Rosado D.
    Int J Pharm; 2009 Jun 22; 375(1-2):75-83. PubMed ID: 19393305
    [Abstract] [Full Text] [Related]

  • 17.
    Shan L.
    ; 2004 Jun 22. PubMed ID: 20641937
    [Abstract] [Full Text] [Related]

  • 18.
    Shan L.
    ; 2004 Jun 22. PubMed ID: 20641903
    [Abstract] [Full Text] [Related]

  • 19. The diagnostic role of 99mTc-dual receptor targeted probe and targeted peptide bombesin (RGD-BBN) SPET/CT in the detection of malignant and benign breast tumors and axillary lymph nodes compared to ultrasound.
    Ji T, Sun Y, Chen B, Ji B, Gao S, Ma Q, Cheng G, Zhang H.
    Hell J Nucl Med; 2015 Jun 22; 18(2):108-13. PubMed ID: 26187209
    [Abstract] [Full Text] [Related]

  • 20. Axillary lymph node metastases detection with 99mTc-sestamibi scintimammography in patients with breast cancer undergoing curative surgery.
    Lumachi F, Ferretti G, Povolato M, Bui F, Cecchin D, Marzola MC, Zucchetta P, Basso U.
    Anticancer Res; 2007 Jun 22; 27(4C):2949-52. PubMed ID: 17695476
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.